TrialInternational journal of molecular sciences2020

Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy.

Serena Di Cosimo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.